Technical Analysis for NURO - NeuroMetrix, Inc.

Grade Last Price % Change Price Change
grade A 1.24 -6.77% -0.09
NURO closed down 6.77 percent on Wednesday, January 16, 2019, on 1.85 times normal volume. It was able to bounce off of its 200 day moving average, an important long-term support line. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical NURO trend table...

Date Alert Name Type % Chg
Jan 16 200 DMA Support Bullish 0.00%
Jan 16 Calm After Storm Range Contraction 0.00%
Jan 16 Wide Range Bar Range Expansion 0.00%
Jan 16 Upper Bollinger Band Walk Strength 0.00%
Jan 16 Wide Bands Range Expansion 0.00%
Jan 16 Overbought Stochastic Strength 0.00%
Jan 16 Upper Bollinger Band Touch Strength 0.00%
Jan 15 Crossed Above 200 DMA Bullish -6.77%
Jan 15 Expansion Breakout Bullish Swing Setup -6.77%
Jan 15 Pocket Pivot Bullish Swing Setup -6.77%

Older signals for NURO ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
NeuroMetrix, Inc., a medical device company, develops and markets products for the detection, diagnosis, and monitoring of peripheral nerve and spinal cord disorders, such as those associated with carpal tunnel syndrome, lumbosacral disc disease, spinal stenosis, and diabetes. The company focuses on the diagnosis and treatment of neurological complications of diabetes, including diabetic peripheral neuropathy (DPN) and median neuropathy. Its marketed products include NC-stat DPNCheck, a device used to evaluate systemic neuropathies, such as DPN at the point-of-care; SENSUS pain therapy device, a transcutaneous electrical nerve stimulator used for chronic and intractable pain relief; and ADVANCE NCS/EMG system, a platform for the performance of traditional nerve conduction studies and invasive electromyography procedures for the assesment of CTS, low back and leg pain, and DPN, as well as consumables and accessories. The company is also developing SENTINEL device that provides sensory enhancement in the feet targeted at patients who have lost sensory perception in the lower extremities. NeuroMetrix, Inc. distributes its products directly through its direct sales force and independent sales representatives to physicians, clinics, hospitals, managed care organizations, retail health businesses, and independent distributors consisting of primary care, internal medicine, orthopedic and hand surgeons, pain medicine physicians, neurologists, physical medicine and rehabilitation, physicians, and neurosurgeons, as well as endocrinology and podiatry markets primarily in the United States, the United Kingdom, the Netherlands, and India. The company was founded in 1996 and is headquartered in Waltham, Massachusetts.
Is NURO a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 2.18
52 Week Low 0.6
Average Volume 141,272
200-Day Moving Average 1.2172
50-Day Moving Average 0.932
20-Day Moving Average 0.8775
10-Day Moving Average 1.0265
Average True Range 0.123
ADX 31.82
+DI 35.314
-DI 6.814
Chandelier Exit (Long, 3 ATRs ) 1.011
Chandelier Exit (Short, 3 ATRs ) 0.969
Upper Bollinger Band 1.2565
Lower Bollinger Band 0.4985
Percent B (%b) 0.98
BandWidth 86.381766
MACD Line 0.0805
MACD Signal Line 0.0196
MACD Histogram 0.0609
Fundamentals Value
Market Cap 2.3 Million
Num Shares 1.86 Million
EPS -19.02
Price-to-Earnings (P/E) Ratio -0.07
Price-to-Sales 0.21
Price-to-Book 0.63
PEG Ratio -0.01
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.66
Resistance 3 (R3) 1.66 1.52 1.59
Resistance 2 (R2) 1.52 1.41 1.52 1.57
Resistance 1 (R1) 1.38 1.35 1.31 1.38 1.54
Pivot Point 1.24 1.24 1.21 1.24 1.24
Support 1 (S1) 1.10 1.13 1.03 1.10 0.94
Support 2 (S2) 0.96 1.07 0.96 0.91
Support 3 (S3) 0.82 0.96 0.89
Support 4 (S4) 0.82